Macquarie Group Portfolio holdings
Top Buys
| 1 |
CVS Health
CVS
|
+$836M |
| 2 |
Cardinal Health
CAH
|
+$796M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$766M |
| 4 |
Intel
INTC
|
+$763M |
| 5 |
Verizon
VZ
|
+$761M |
Top Sells
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$737M |
| 2 |
Bausch Health
BHC
|
+$71M |
| 3 |
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
|
+$51.2M |
| 4 |
HPY
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
|
+$36.1M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$22.1M |
Sector Composition
| 1 | Healthcare | 16.98% |
| 2 | Financials | 13.97% |
| 3 | Industrials | 10.97% |
| 4 | Technology | 10.76% |
| 5 | Energy | 10.33% |
Similar funds
Macquarie Group's Q2 2016 Portfolio in Review
As of Q2 2016, Macquarie Group held 1,714 positions worth $102B, up 106% from $49.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Macquarie Group deployed $49.1B of net new capital in Q2 2016, opening 159 new positions and adding to 1,288 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 1,161,694 shares worth $113M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was BAXALTA INC COM STK (DE), an estimated $737M trimmed.
- Macquarie Group's largest Q2 2016 buy was iShares Russell 2000 Value ETF: 1,161,694 shares worth $113M.
- Macquarie Group added most to CVS Health in Q2 2016, an estimated $836M increase.
- Macquarie Group's biggest Q2 2016 reduction was BAXALTA INC COM STK (DE), cutting an estimated $737M.
- Macquarie Group fully exited Bausch Health in Q2 2016, selling an estimated $71M.
- Macquarie Group's ten largest holdings make up 15% of its $102B portfolio in Q2 2016.
- Macquarie Group opened 159 new positions and closed 149 in Q2 2016.
- Macquarie Group's portfolio value rose 106% quarter-over-quarter to $102B.
Based on Macquarie Group's 13F filing for Q2 2016, filed 15 Aug 2016.